[Federal Register Volume 81, Number 217 (Wednesday, November 9, 2016)]
[Notices]
[Page 78864]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-27005]



[[Page 78864]]

=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (16-080)]


Notice of Intent To Grant an Exclusive License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of intent to grant an exclusive license.

-----------------------------------------------------------------------

SUMMARY: The National Aeronautics and Space Administration (NASA) 
hereby gives notice of its intent to grant an exclusive license, in the 
field of use of human and/or animal healthcare, in the Australia, 
Brazil, Canada, China, Chile, Colombia, Hong Kong, European Union 
(EPO), India, Indonesia, Israel, Japan, Malaysia, Mexico, New Zealand, 
Philippines, Russia, Saudi Arabia, Singapore, South Africa, South 
Korea, United States and Vietnam, to practice the inventions described 
and claimed in Patent Cooperative Treaty (PCT) Application Number PCT/
US15/20964 and national/regional phase patent applications resulting 
therefrom, titled ``Infrasonic Stethoscope for Monitoring Physiological 
Processes,'' NASA Case Number LAR-18509-1-PCT, to Infrasonix Inc., 
having its principal place of business in Lawrenceville, GA. Certain 
patent rights in these inventions have been assigned to the United 
States of America as represented by the Administrator of the National 
Aeronautics and Space Administration. The prospective exclusive license 
will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 
404.7.

DATES: The prospective exclusive license may be granted unless, within 
fifteen (15) days from the date of this published notice, NASA receives 
written objections including evidence and argument that establish that 
the grant of the license would not be consistent with the requirements 
of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and 
received by NASA within fifteen (15) days of the date of this published 
notice will also be treated as objections to the grant of the 
contemplated partially exclusive license.
    Objections submitted in response to this notice will not be made 
available to the public for inspection and, to the extent permitted by 
law, will not be released under the Freedom of Information Act, 5 
U.S.C. 552.

ADDRESSES: Objections relating to the prospective license may be 
submitted to Patent Counsel, Office of Chief Counsel, NASA Langley 
Research Center, MS 30, Hampton, VA 23681; (757) 864-3221 (phone), 
(757) 864-9190 (fax).

FOR FURTHER INFORMATION CONTACT: Andrea Z. Warmbier, Patent Attorney, 
Office of Chief Counsel, NASA Langley Research Center, MS 30, Hampton, 
VA 23681; (757) 864-7686; Fax: (757) 864-9190. Information about other 
NASA inventions available for licensing can be found online at http://technology.nasa.gov. This notice is issued in accordance with 35 U.S.C. 
209(e) and 37 CFR 404.7(b)(1)(i).

Mark P. Dvorscak,
Agency Counsel for Intellectual Property.
[FR Doc. 2016-27005 Filed 11-8-16; 8:45 am]
 BILLING CODE 7510-13-P